NAFEMS Training Webinar: In Silico Tests/Trials of Medical Products for the Digital Era

Описание: About UK CEiRSI
The UK’s first Centre of Excellence in In-Silico Regulatory Science and Innovation (UK CEiRSI) advances computational evidence in healthcare, bringing together academia, industry, and regulators to shape global standards.

About this webinar
Computational Medicine underpins In-silico trials (IST), i.e., computer-based trials of medical products performed on populations of digital twins (aka virtual patients). Computer models/simulations are used to conceive, develop, and assess devices with the intended clinical outcome explicitly optimised from the outset (a-priori) instead of tested on humans (a-posteriori). This will include testing for potential risks to patients (side effects) and exhaustively exploring medical device failure modes before being tested in human clinical trials. In-silico evidence is still consolidating but is poised to transform how health and life sciences R&D and regulations are conducted. UK can take a leadership position in in-silico trials, which would cement its position as a global leader in health and life sciences, help drive the UK economy and provide UK citizens with early access to innovative health products.

In this talk, Prof Alex Frangi and Dr Puja Myles will introduce you to this world of new possibilities and summarise progress made in this new paradigm among academia, industry, regulators, and policymakers.

Webinar hosts
Dr Alex Frangi, Director of UK CEiRSI, University of Manchester
Dr Puja Myles, Director of the Clinical Practice Research Datalink, MHRA

Connect with the UK CEiRSI Community:
Our LinkedIn Hub:   / ukceirsi  
Our Eventbrite Page: https://www.eventbrite.co.uk/o/uk-cei...
Our YouTube Channel:    / @uk-ceirsi  

Connect with the InSilico UK Community:
Our Webpage: https://www.insilicouk.org
Our Publications: https://www.zenodo.org/communities/in...
Our Podcast: https://www.insilicouk.podbean.com
Our LinkedIn Group:   / 9169266